Portfolio

HLEND seeks to build a diversified portfolio of senior secured private credit investments in resilient, market-leading, upper-middle market companies that operate primarily in non-cyclical sectors.

Data as of July 31, 2025

$21.5B

Investments at Fair Value

10.0%

Portfolio Yield at Fair Value1

91%

Private Investments2

97%

First Lien Exposure3

99%

Floating Rate4

$238M

Weighted Average EBITDA5

Portfolio Companies89

Clear Filters
Company Name
Industry
Investment Type
Reference Rate & Spread11
Par Amount (thousands)
Amortized Cost (thousands)
Fair Value (thousands)
% of Total Portfolio
Armstrong Bidco Limited (Access Group) Software and Computer Services 1st Lien Senior Secured Debt SN + 5.00% £139,986 166,660 184,908 0.86%
Ark Newco Limited (Away Resorts) Travel and Leisure Preferred Equity £7,884 10,210 9,831 0.05%
Ark Newco Limited (Away Resorts) Travel and Leisure Equity and other investments £1 - - 0.00%
Argos Health Holdings, Inc. Industrial Support Services 1st Lien Senior Secured Debt SF + 5.50% $643 638 642 0.00%
Ares Secondaries Pbn Finance Co IV LLC (Ares Secondaries Pbn Finance Co IV LLCFO) Structured Finance Structured Finance investments SF + 2.90% $1,000 10 10 0.00%
Ares Secondaries Pbn Finance Co IV LLC (Ares Secondaries Pbn Finance Co IV LLCFO) Structured Finance Structured Finance investments SF + 8.50% $5,000 52 52 0.00%
Arcfield Acquisition Corp (TigerCub) Aerospace and Defense 1st Lien Senior Secured Debt SF + 5.00% $92,386 81,080 81,580 0.38%
Arc Media Holdings Limited Media 1st Lien Senior Secured Debt SF + 7.25% $42,680 41,766 41,602 0.19%
Apex Group Treasury LLC (Apex Group) Investment Banking and Brokerage Services 1st Lien Senior Secured Debt SF + 3.50% $13,548 13,422 13,570 0.06%
Amynta Agency Borrower Inc (Amynta) Non-life Insurance 1st Lien Senior Secured Debt SF + 2.75% $20,040 19,684 20,073 0.09%
Amneal Pharmaceuticals LLC (Amneal Pharmaceuticals) Pharmaceuticals and Biotechnology 1st Lien Senior Secured Debt SF + 3.50% $7,800 7,781 7,818 0.04%
American Academy Holdings, LLC (American Academy of Professional Coders) Consumer Services 1st Lien Senior Secured Debt SF + 9.75% (incl 5.25% PIK) $57,912 57,912 57,165 0.27%
AmWINS Group Inc (AmWINS Group, Inc.) Non-life Insurance 1st Lien Senior Secured Debt SF + 2.25% $10,168 10,156 10,187 0.05%
Altar Bidco Inc (Brooks Automation) Technology Hardware and Equipment 1st Lien Senior Secured Debt SF + 3.10% $8,735 8,696 8,741 0.04%
Alpine US Bidco LLC (Aspire Bakeries) Food Producers 1st Lien Senior Secured Debt SF + 3.50% $9,490 9,457 9,588 0.04%
Allied Universal Holdco LLC (Allied Universal) Industrial Support Services 1st Lien Senior Secured Debt SF + 3.75% $14,886 14,817 14,935 0.07%
Alliant Holdings Intermediate, LLC (Alliant Insurance Services, Inc.) Non-life Insurance 1st Lien Senior Secured Debt SF + 2.50% $18,604 18,467 18,626 0.09%
Alliant Holdings Intermediate LLC / Alliant Holdings Co-Issuer (Alliant Insurance Services, Inc.) Non-life Insurance Unsecured Debt 6.75% $6,255 5,962 6,266 0.03%
Alera Group Intermediate Holdings, Inc. (Alera Group, Inc.) Non-life Insurance 1st Lien Senior Secured Debt SF + 3.25% $8,000 7,961 8,045 0.04%
Alchemy US Holdco 1 LLC (Kymera International) Industrial Metals and Mining 1st Lien Senior Secured Debt E + 6.50% €25,283 26,404 27,877 0.13%
Alchemy US Holdco 1 LLC (Kymera International) Industrial Metals and Mining 1st Lien Senior Secured Debt SF + 6.50% $130,072 116,515 116,720 0.54%
Agiliti Health, Inc. (Universal Hospital Services, Inc.) Medical Equipment and Services 1st Lien Senior Secured Debt SF + 3.00% $5,404 5,122 5,255 0.02%
Aesthetics Australia Group Pty Ltd (Laser Clinics Group) Consumer Services 1st Lien Senior Secured Debt B + 8.31% (incl 4.06% PIK) AUD 57,807 36,859 32,906 0.15%
Advarra Holdings, Inc. (Advarra, Inc.) Pharmaceuticals and Biotechnology 1st Lien Senior Secured Debt SF + 4.50% $201,358 193,697 197,351 0.92%
Acuris Finance US, Inc (ION Analytics) Software and Computer Services 1st Lien Senior Secured Debt SF + 3.75% $8,320 8,223 8,335 0.04%

Engage with HLEND

Start Here

Footnotes

  1. Computed as (a) the annual stated interest rate or yield plus the annual accretion of discounts and less any annual amortization of premiums, as applicable, on accruing (i) debt and (ii) other income producing securities, divided by (b) total accruing (i) debt and (ii) other income producing securities (at fair value). Actual yields earned over the life of each investment could differ materially from the yields presented above. Please refer to HLEND’s prospectus and filings, including Form 10-Q or Form 10-K for fair value disclosures.
  2. Private Investments represents level 3 investments in the investment portfolio where inputs to the valuation methodology are unobservable and significant to overall fair value measurement. Private investments includes investments in joint ventures.
  3. Based on the aggregate fair value of the investment portfolio as of July 31, 2025.
  4. Percentage based on aggregate fair value of accruing debt.
  5. Calculated with respect to all level 3 investments (or, with respect to weighted average loan to value, all level 3 debt investments) in the investment portfolio for which fair value is determined by the Investment Adviser (in its capacity as the investment adviser of HLEND, with assistance, at least quarterly, from a third-party valuation firm, and overseen by HLEND’s Board of Trustees), and excludes quoted assets and investments in joint ventures. In the case of weighted average EBITDA only, excludes investments with no reported EBITDA or where EBITDA, in the Investment Adviser’s judgement made in its discretion, was not a material component of the original investment thesis, such as loan-to-value-based loans, NAV-based loans or reorganized equity. Weighted average EBITDA is weighted based on the fair value of the total applicable level 3 investments. Loan to value is calculated as net debt through each respective investment tranche in which HLEND holds an investment divided by enterprise value or value of underlying collateral of the portfolio company. Weighted average loan to value is weighted based on the fair value of the total applicable level 3 debt investments. Excludes investments on non-accrual status as of October 31, 2024. Figures are derived from the most recent financial statements from portfolio companies.
  6. Includes “last out” portions of first lien senior secured loans.
  7. Secured debt at the holding company level.
  8. Based on FTSE / DJ Industry Classification Benchmark (“ICB”) sector definition. Totals may not sum due to rounding.
  9. All figures are as of July 31, 2025 unless otherwise indicated. % of total portfolio shown above is measured as total fair value of investments.
  10. Other includes structured finance investments.
  11. Contractual rates on preferred equity investments may represent preference accruals that are not recognized through investment income of the fund and as such are not included in the calculation of yield. The fair value of these investments may be influenced by the stated preference accrual or a minimum return threshold.